Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥2,777 JPY
Change Today +97.00 / 3.62%
Volume 32.8K
4585 On Other Exchanges
Symbol
Exchange
Tokyo
As of 11:32 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for umn pharma inc (4585)

Year over year, UMN Pharma Inc. has been seen their bottom line shrink from a loss of ¥3.7B JPY to an even larger loss of ¥4.0B JPY. despite revenues that grew from ¥93.0M JPY to ¥1.1B JPY over the same time period.
View Income Statement In U.S. Dollar
Currency in
Millions of Japanese Yens
As of:Dec 31
2011
JPY
Dec 31
2012
JPY
Dec 31
2013
JPY
Dec 31
2014
JPY
4 Year
Trend
Revenues1,000.0108.093.01,108.0
TOTAL REVENUES1,000.0108.093.01,108.0
Cost of Goods Sold160.017.027.0174.0
GROSS PROFIT840.091.066.0934.0
Selling General & Admin Expenses, Total1,915.0514.0563.0607.0
R&D Expenses--1,649.03,925.04,270.0
OTHER OPERATING EXPENSES, TOTAL1,915.02,163.04,488.04,877.0
OPERATING INCOME-1,075.0-2,072.0-4,422.0-3,943.0
Interest Expense-4.0-72.0-225.0-168.0
Interest and Investment Income----1.0--
NET INTEREST EXPENSE-4.0-72.0-224.0-168.0
Currency Exchange Gains (Loss)---1.0-2.0-5.0
Other Non-Operating Income (Expenses)-1.0-507.0469.0-133.0
EBT, EXCLUDING UNUSUAL ITEMS-1,080.0-2,652.0-4,179.0-4,249.0
Gain (Loss) on Sale of Investments----38.0--
Gain (Loss) on Sale of Assets-2,801.0------
Other Unusual Items, Total3,169.0----247.0
Other Unusual Items3,171.0----2,213.0
EBT, INCLUDING UNUSUAL ITEMS-712.0-2,652.0-4,141.0-4,002.0
Income Tax Expense10.04.081.03.0
Minority Interest in Earnings245.0660.0505.044.0
Earnings from Continuing Operations-722.0-2,656.0-4,222.0-4,005.0
NET INCOME-477.0-1,996.0-3,717.0-3,961.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-477.0-1,996.0-3,717.0-3,961.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-477.0-1,996.0-3,717.0-3,961.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4585:JP ¥2,777.00 JPY +97.00

4585 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4585.
View Industry Companies
 

Industry Analysis

4585

Industry Average

Valuation 4585 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 337.8x
Price/Book 16.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 213.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UMN PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.